Moving to better COPD care—changes to and challenges for GOLD.
COPD care: Key changes and challenges in GOLD 2026
A more proactive approach to COPD care
This is a summary of the key changes, why they matter, and what evidence is needed. We believe there is a need for fundamental change to a more proactive and ambitious approach to address the many problems that continue to impede transformational progress in the care of patients with chronic obstructive pulmonary disease (COPD).
Current gaps in COPD care
Currently patients are diagnosed too late, the extent of their disease is not thoroughly characterized, too little emphasis is placed on assessing exacerbation risk and comorbidities, and patients are often insufficiently treated.
Prevention and more ambitious COPD care outcomes
All in all, these are exciting times for COPD care. Yet, to realize the full potential of the presented concepts for diagnosis, assessment, and management, we have to change our attitude: The focus needs to be prevention instead of treatment and our treatment paradigm proactive instead of reactive, with more ambitious objectives for outcomes.
Authors
Claus F Vogelmeier, David M G Halpin, Gerard J Criner, Fernando J Martinez, Dave Singh, Antonio Anzueto, Alvar Agusti, the GOLD Science Committee
Read more details at
Fecha de publicación
08 July 2026 — online publication date. The article appears in the October 2026 issue. academic.oup.com
Categorías asociadas al artículo
Noticias relacionadas
A GOLD Science Committee Report on Universal Longitudinal Spirometry: A New Paradigm
Universal longitudinal spirometry from childhood: GOLD proposes monitoring lung function trajectories to preserve lifelong respiratory health.
Bronchial and Systemic Relationships of Haemophilus in Chronic Obstructive Pulmonary Disease
Haemophilus in COPD: a study of bronchial microbiome composition, exacerbation patterns, hospital admissions and relationships with blood interleukin-8 levels.
A Proposed Consensus Definition of Severe
Explore a proposed consensus definition of severe COPD and a structured work-up addressing symptoms, functional impairment, quality of life and clinical characteristics.
Awareness of chronic obstructive pulmonary disease in the adult population of seven African cities: a comparative analysis with asthma and HIV from the RACE Africa study
COPD awareness in Africa is low: the RACE Africa survey in seven cities finds limited knowledge of risk factors and symptoms compared with asthma and HIV.
Using AI for COPD Diagnosis, Equity, Guideline Gaps: Alvar Agusti, MD, PhD
AI in COPD diagnosis can support case finding, spirometry interpretation and equity while GOLD 2026 highlights validation and guideline gaps.
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
Astegolimab for COPD was evaluated in the ALIENTO and ARNASA trials to assess its efficacy and safety in patients with frequent exacerbations.
Imagen desarrollada ChatGPT